Terms: = Germ cell tumor AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
1060 results:
1. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
[TBL] [Abstract] [Full Text] [Related]
2. PKM2 promotes glioma progression by mediating CTNNB1 expression.
Ma C; Feng Y; Zhong K; Wei J
Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
[TBL] [Abstract] [Full Text] [Related]
3. α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation.
Li X; Meng X; Fan H; Wang Y; Jia Y; Jiao J; Ma X
Arch Dermatol Res; 2024 May; 316(6):269. PubMed ID: 38795191
[TBL] [Abstract] [Full Text] [Related]
4. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma.
Zhao J; Cui X; Zhan Q; Zhang K; Su D; Yang S; Hong B; Wang Q; Ju J; Cheng C; Li C; Wan C; Wang Y; Zhou J; Kang C
Theranostics; 2024; 14(7):2835-2855. PubMed ID: 38773970
[No Abstract] [Full Text] [Related]
5. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract] [Full Text] [Related]
6. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling.
Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607
[TBL] [Abstract] [Full Text] [Related]
7. Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes.
Abdelrahman Z; Abdelatty A; Luo J; McKnight AJ; Wang X
Comput Biol Med; 2024 Jun; 175():108304. PubMed ID: 38663352
[TBL] [Abstract] [Full Text] [Related]
8. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
9. STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma.
Khan MT; Almas M; Malik N; Jalota A; Sharma S; Ali SA; Luthra K; Suri V; Suri A; Basak S; Seth P; Chosdol K; Sinha S
Cell Signal; 2024 Jul; 119():111178. PubMed ID: 38640981
[TBL] [Abstract] [Full Text] [Related]
10. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
Zhou S; Xu J; Zhu Y
Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689
[TBL] [Abstract] [Full Text] [Related]
11. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
Zhang W; Zhang L; Dong H; Peng H
Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D
Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802
[TBL] [Abstract] [Full Text] [Related]
13. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.
Bibbò F; Asadzadeh F; Boccia A; Sorice C; Bianco O; Saccà CD; Majello B; Donofrio V; Bifano D; De Martino L; Quaglietta L; Cristofano A; Covelli EM; Cinalli G; Ferrucci V; De Antonellis P; Zollo M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612726
[TBL] [Abstract] [Full Text] [Related]
14. PSMA2 promotes glioma proliferation and migration via emt.
Zhang Y; Xiang Z; Chen L; Deng X; Liu H; Peng X
Pathol Res Pract; 2024 Apr; 256():155278. PubMed ID: 38574629
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of melanoma cell migration and invasion by natural coumarin auraptene through regulating emt markers and reducing MMP-2 and MMP-9 activity.
Hosseini F; Ahmadi A; Hassanzade H; Gharedaghi S; Rassouli FB; Jamialahmadi K
Eur J Pharmacol; 2024 May; 971():176517. PubMed ID: 38537805
[TBL] [Abstract] [Full Text] [Related]
16. PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Paris J; Wilhelm C; Lebbé C; Elmallah M; Pamoukdjian F; Héraud A; Gapihan G; Walle AV; Tran VN; Hamdan D; Allayous C; Battistella M; Van Glabeke E; Lim KW; Leboeuf C; Roger S; Falgarone G; Phan AT; Bousquet G
Clin Transl Med; 2024 Mar; 14(3):e1632. PubMed ID: 38515278
[TBL] [Abstract] [Full Text] [Related]
17. Bisphenol A: Unveiling Its Role in Glioma Progression and tumor Growth.
Niu L; Jia J; Yang H; Liu S; Wang H; Yan Y; Li Q; Dong Q; Zhang H; Zhao G; Dai J; Yuan G; Pan Y
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473752
[TBL] [Abstract] [Full Text] [Related]
18. The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
Ye Z; Li Q; Hu Y; Hu H; Xu J; Guo M; Zhang W; Lou X; Wang Y; Gao H; Jing D; Fan G; Qin Y; Zhang Y; Chen X; Chen J; Xu X; Yu X; Liu M; Ji S
Cancer Lett; 2024 Apr; 588():216769. PubMed ID: 38438098
[TBL] [Abstract] [Full Text] [Related]
19. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.
Shirley CA; Chhabra G; Amiri D; Chang H; Ahmad N
Front Immunol; 2024; 15():1336023. PubMed ID: 38426087
[TBL] [Abstract] [Full Text] [Related]
20. Twist-1 Stimulates the Malignant Behaviors of Hydatidiform Mole via the PI3K/AKT Pathway.
Zhang C; Song Y; Yin Y; Hou H; Ge Z
Discov Med; 2024 Feb; 36(181):286-293. PubMed ID: 38409834
[TBL] [Abstract] [Full Text] [Related]
[Next]
